Skip to content

Newsroom

type
year
Illustration image.png

Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics

1/30/2025 Press release
Illustration image.png

Orion publishes Financial Statement Release for 2024 and holds a webcast on 25 February 2025

1/28/2025 Press release
Illustration image.png

Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide

1/7/2025 Press release
Illustration image.png

Orion and Marinus terminate agreement for ganaxolone in Europe

12/30/2024 Press release
Illustration image.png

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics

12/18/2024 Press release
Illustration image.png

Orion Research Foundation grants EUR 1,109,000 for research in 2025

11/22/2024 Press release
Illustration image.png

Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies

11/19/2024 Press release
Illustration image.png

Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024

10/15/2024 Press release
Illustration image.png

Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU

10/14/2024 Press release
Illustration image.png

Orion’s near-term climate targets approved by the Science Based Targets initiative

9/30/2024 Press release
Illustration image.png

Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster

9/26/2024 Press release
Illustration image.png

Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology

9/25/2024 Press release
Illustration image.png

Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer

9/16/2024 Press release
Illustration image.png

Orion publishes Half-Year Financial Report for January–June 2024 and holds a webcast on 8 August 2024

7/25/2024 Press release
Illustration image.png

Orion is developing the Finnish life science industry in a unique collaboration project

6/3/2024 Press release
Illustration image.png

Orion publishes Interim Report for January–March 2024 and holds a webcast on 25 April 2024

4/11/2024 Press release
Illustration image.png

The change negotiations concerning Orion’s Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plant

3/22/2024 Press release
Illustration image.png

Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally

2/22/2024 Press release